News

Mice carrying the Met68BDNF gene variant would consume excessive amounts of alcohol.

Researchers at the Aortic Institute at Yale have tested the genomes of more than 100 patients with thoracic aortic aneurysms, a potentially lethal condition, and provided genetically personalized care.

Resveratrol and quercetin, two polyphenols that have been widely studied for their health properties, may soon become the basis of an important new advance in cancer treatment,

The company has announced the receipt of Phase I SBIR grant funds from the National Institute of Health (NIH) to further its CRISPR-mediated genome-editing program.

A recent study has revealed a novel workflow, identifying associations between molecules to provide insights into cellular metabolism and gene expression in complex biological systems.

A study led by OHSU researchers has revealed a critical first step in developing a new gene and stem cell regenerative technique for treating patients with mitochondrial disease.

The American College of Medical Genetics and Genomics has issued five recommendations that patients and their doctors should consider and discuss before ordering genetic testing.

Researchers have developed a network for describing protein-protein interactions that can then be used to examine protein interactions that may have biological or clinical significance.

Learn about the next generation of microarrays in one of the best attended workshops of the conference.

Rubicon Genomics today announced it has secured $2 million in growth capital financing.